globalbarry. Company Intelligence Engine

Aktis Oncology, Inc.

AKTS CIK 0002035832 · Pharmaceutical Preparations (SIC 2834)

Disclosed SEC business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210

Aktis Oncology, Inc. (ticker AKTS, CIK 0002035832) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

54 exposure relationships mapped 54 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Pharmaceutical Preparations (SIC 2834)
  • FACT Country of disclosed business address: United States
  • FACT 4 filed (period 2026-09-23) 2026-09-24 source ↗

You've reached this month's free company deep views

The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.

Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.